Innsbruck, Austria -  September 9, 2025: DeepOpinion, the category-defining platform for Agentic Process Automation, today announced it has been mentioned in Gartner’s Report: “Emerging Tech: Top-Funded Startups for Domain-Specialized Agentic AI.” Gartner’s research provides insights that global enterprises look to when evaluating technology providers in the automation and AI markets.

DeepOpinion transforms how enterprises automate mission-critical, unstructured processes end-to-end. Its agentic-native platform consistently delivers 90%+ automation rates across multi-step workflows, such as claims handling, procure-to-pay and customer service, all orchestrated seamlessly across ERP, CRM, BPM, and legacy systems.

“Our mission is to fundamentally transform enterprise operations, establishing the 'autonomous enterprise' as the definitive model for all companies,” said Stefan Engl, CEO and Co-Founder of DeepOpinion. “We are excited to be mentioned in this Gartner report.”

DeepOpinion has rapidly expanded across industries such as insurance, banking, and manufacturing. Enterprises including Allianz, Siemens, and Hannover Re run the platform live in production to process millions of documents and cases annually, unlocking millions in operational savings.

The 2025 Gartner® Emerging Tech: Top-Funded Startups for Domain-Specialized Agentic AI is available to Gartner clients at https://www.gartner.com/en/documents/6892566.

Gartner, Emerging Tech: Top-Funded Startups for Domain-Specialized Agentic AI, Akhil Singh, Aakanksha Bansal, Alfredo Ramirez IV, Anushree Verma, Danielle Casey, 28 August 2025

‍

Required Disclaimer

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

‍